International Journal of Radiation Oncology * Biology * Physics
Volume 54, Issue 5 , Pages 1558-1564 , 1 December 2002

Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning

  • Takashi Mizowaki, M.D., Ph.D.

      Affiliations

    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • Department of Therapeutic Radiology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Gil’ad N Cohen, M.S.

      Affiliations

    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Albert Y.C Fung, Ph.D.

      Affiliations

    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    • ,
  • Marco Zaider, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: Marco Zaider, Ph.D., Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 USA. Tel: (212) 639-7125; Fax: (212) 717-3791
    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Received 4 January 2002 ,Revised 2 August 2002 ,Accepted 5 August 2002.

References 

  1. Ling CC, Humm J, Larson S, et al.  Towards multidimensional radiotherapy (MD-CRT) (Biological imaging and biological conformality). Int J Radiat Oncol Biol Phys. 2000;47:551–560
  2. Zaider M, Zelefsky MJ, Lee EK, et al.  Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2000;47:1085–1096
  3. Rosenman J. Incorporating functional imaging information into radiation treatment. Semin Radiat Oncol. 2001;11:83–92
  4. Thornbury JR, Ornstein DK, Choyke PL, et al.  Prostate cancer (What is the future role for imaging?). AJR Am J Roentgenol. 2001;176:17–22
  5. Kurhanewicz J, Vigneron DB, Hricak H, et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7-cm3) spatial resolution. Radiology. 1996;198:795–805
  6. Kurhanewicz J, Vigneron DB, Males RG, et al.  The prostate (MR imaging and spectroscopy. Present and future). Radiol Clin North Am. 2000;38:115–138 viii–ix
  7. Kurhanewicz J, Vigneron DB, Nelson SJ, et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone (Detection via localized proton spectroscopy). Urology. 1995;45:459–466
  8. Kurhanewicz J, Dahiya R, Macdonald JM, et al.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas (1H magnetic resonance spectroscopy and biochemical study). Magn Reson Med. 1993;29:149–157
  9. Costello LC, Franklin RB, Narayan P. Citrate in the diagnosis of prostate cancer. Prostate. 1999;38:237–245
  10. Scheidler J, Hricak H, Vigneron DB, et al.  Prostate cancer (Localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study). Radiology. 1999;213:473–480
  11. Zelefsky MJ, Cohen G, Zakian KL, et al.  Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J. 2000;6:249–255

PII: S0360-3016(02)03805-1

doi: 10.1016/S0360-3016(02)03805-1

International Journal of Radiation Oncology * Biology * Physics
Volume 54, Issue 5 , Pages 1558-1564 , 1 December 2002

Article Tools

* Image Usage & Resolution